{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:22:59Z","timestamp":1785288179822,"version":"3.55.0"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":1425,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Endometriosis, the presence of endometrial tissue outside the uterus, is a progressive, estrogen\u2010dependent disease and occurs nearly exclusively in menstruating women of reproductive age. Pain syndrome, however, represents the major clinical problem of this disease, manifested as dysmenorrhea, pelvic pain, lower abdominal pain, and dyspareunia. The manifestation of the disease, that is, the pain syndrome, rather than the disease itself currently represents the major indication for both the medical and surgical therapies of endometriosis. The major drawbacks of current medical therapies of endometriosis are sometimes severe side effects. In this review, selective progesterone receptor modulators (SPRMs, mesoprogestins) as a potential therapeutic concept in endometriosis are discussed. Due to endometrial selectivity and favorable pharmacological profile, SPRMs may have advantages over the current medical treatments of this disease. Other emerging therapeutic approaches for this disease are also mentioned.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2002.tb02798.x","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T17:57:33Z","timestamp":1247162253000},"page":"373-388","source":"Crossref","is-referenced-by-count":57,"title":["Selective Progesterone Receptor Modulators (SPRMs)"],"prefix":"10.1111","volume":"955","author":[{"given":"KRISTOF","family":"CHWALISZ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAMESH","family":"GARG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT M.","family":"BRENNER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GERD","family":"SCHUBERT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WALTER","family":"ELGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/4.5.736"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-199909000-00019"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb21763.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70482-4"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107263450407"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(00)00178-1"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm001000c"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-1-156"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/4.5.570"},{"key":"e_1_2_6_11_2","first-page":"2","article-title":"Antiprogestational steroids: a new dimension in human fertility regulation","volume":"11","author":"Look P.","year":"1989","journal-title":"Oxf. Rev. Reprod. Biol."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(93)90133-R"},{"key":"e_1_2_6_13_2","first-page":"47","article-title":"Mechanism of action of progesterone antagonists in pregnant guinea pigs","volume":"6","author":"Elger W.","year":"1986","journal-title":"Contraception"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/9.suppl_1.131"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(87)80134-5"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(00)00190-2"},{"key":"e_1_2_6_17_2","first-page":"221A","article-title":"A comparison of the endometrial antiproliferative effects of a mesoprogestin (J1042) with the antiprogestins ZK 137 316 and ZK 230 211 in cynomolgus monkeys","volume":"7","author":"Chwalisz K.","year":"2000","journal-title":"J. Soc. Gynecol. Invest."},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.2.269"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.8.1562"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.8.1557"},{"key":"e_1_2_6_21_2","unstructured":"Brenner R.M. & O.D. Slayden. 1994. Cyclic changes in the primate oviduct and endometrium.InThe Physiology of Reproduction. Chapter 10 pp. 541\u2010569. Raven Press. New York."},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0015-0282(16)53174-4","article-title":"Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen\u2010stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys","volume":"52","author":"Wolf J.P.","year":"1989","journal-title":"Fertil. Steril."},{"key":"e_1_2_6_23_2","first-page":"171","article-title":"Contraceptive potential of RU 486 by ovulation inhibition: I","volume":"40","author":"Uem J.F.H.M.","year":"1989","journal-title":"Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation. Contraception"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.2.440"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.6.2668"},{"key":"e_1_2_6_26_2","first-page":"87A","article-title":"Changes in nitric oxide synthase are down\u2010regulated by antiprogesterone in the stimulated\u2010pregnant baboon uterus","volume":"7","author":"Purcell T.L.","year":"2000","journal-title":"J. Soc. Invest."},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1986.tb02520.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-62-1-16"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)93307-5"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.140.6.2672"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0890-6238(98)00003-3"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/6.5.413"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2002.tb02798.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2002.tb02798.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T20:41:31Z","timestamp":1695674491000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2002.tb02798.x"}},"subtitle":["A Novel Therapeutic Concept in Endometriosis"],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1111\/j.1749-6632.2002.tb02798.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb02798.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}